PIA
GSK icon

Peachtree Investment Advisors’s GSK GSK Stock Holding History

Peachtree Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-65
Closed -$4K – 309
2015
Q1 		$4K Hold
65
– – ﹤0.01% 290
2014
Q4 		$3K Hold
65
– – ﹤0.01% 330
2014
Q3 		$4K Buy
+65
New +$3.98K ﹤0.01% 336

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Peachtree Investment Advisors's GSK Position: Q2 2015 in Review

Peachtree Investment Advisors sold out of GSK (GSK) in Q2 2015, closing a stake of 65 shares — an estimated $4K sold.

Peachtree Investment Advisors first reported a position in GSK in Q3 2014 and held it in 3 quarters. The position peaked at $4K in Q1 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Peachtree Investment Advisors reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • Peachtree Investment Advisors sold 65 GSK shares in Q2 2015, an estimated $4K.
  • Peachtree Investment Advisors first reported a position in GSK in Q3 2014 and held it in 3 quarters.
  • Peachtree Investment Advisors's GSK position peaked at $4K in Q1 2015.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Peachtree Investment Advisors's 13F filing for Q2 2015, filed 8 Jul 2015.